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Abstract
We examine how the introduction of smallpox vaccination a¤ected early-life mortality and
fertility in Sweden during the rst half of the 19th century. We demonstrate that parishes
in counties with higher levels of smallpox mortality prior to the introduction of vaccination
experienced a greater decline in infant mortality afterwards. Exploiting this nding in an
instrumental-variable approach reveals that this decline had a negative e¤ect on the birth
rate, while the number of surviving children and population growth remained una¤ected.
These results suggest that the decline in early-life mortality cannot account for the onset
of the fertility decline in Sweden.
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1 Introduction
A crucial question in the eld of economic growth and development is whether health improve-
ments make a population richer (Weil, 2014). The research by Acemoglu and Johnson (2007)
suggests that this is not the case. Central to their argument is that health improvements trans-
late into population increases as people do not die at the same rate as before the improvements.
However, the long-run population e¤ect depends on how fertility adjusts, and the evidence on
this mechanism is scant (Bleakley, 2010). In this paper, we aim to ll this gap in the literature
by investigating the causal e¤ect of early-life mortality on fertility.1
To carry out this investigation, we face the challenge that early-life mortality and fertility
are most likely determined by the same factors of which some are unobservable (see e.g., Schultz,
1997). We address this issue by using pre-vaccination variation in smallpox mortality at the
county level along with time variation arising from the introduction of the smallpox vaccine
to construct an instrument for early-life mortality. The smallpox vaccine was the rst vaccine
successfully developed and the major medical innovation of the late 18th and early 19th century
(Cutler et al., 2006). We focus on the case of Sweden for which historical data on fertility, infant
and child mortality exist at the parish level. Vaccination in Sweden started at the end of 1801
and was widely distributed at zero or low cost to citizens which makes the uptake of vaccine
unlikely to be correlated with regional income levels.2
Exploiting the introduction of the smallpox vaccine to identify the impact of early-life mor-
tality on fertility has a number of appealing features compared to earlier work. First, since
smallpox a¤ected mainly infants, it is much clearer through which mechanism the elimination
of the disease works. Earlier work by Acemoglu and Johnson (2007) and Hansen (2014) use
the timing of elimination of a host of infectious diseases combined with prevalence rates prior
to those interventions to identify the impact of health on wealth.3 In terms of mortality across
1In the literature on the fertility transition, historical evidence indicates that the decline in early-life mortality
cannot account for the fertility decline since it started beforehand (Galor, 2011). By contrast, Kalemli-Ozcan
(2003, 2008) argues that the decline in the uncertainty of the survival rates of children, brought on by lower
child mortality, leads parents to decrease their precautionary demand for children, and this reduces fertility.
2Moreover, Guinnane (2011) lists smallpox vaccination among a list of health inuences that can be re-
garded as exogenous at the household level. Our fertility data are measured at the parish level which is highly
disaggregated, and it seems plausible to assume that smallpox vaccination is also exogenous at this level.
3Using the same type of estimation strategy, Hansen (2013) demonstrates that the decline in infectious-
disease mortality in the second half of the 20th century is positively related to human capital accumulation
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the life cycle, their instrument could work through a much broader set of mechanisms than the
one used in the present paper. Second, since smallpox vaccination was the rst vaccination and
the major medical innovation at the time, it is di¢ cult to think of medical interventions that
occurred at the same time and also correlate with pre-intervention smallpox mortality rates.
Third, Sweden also introduced a compulsory vaccination law in 1816 which adds an additional
plausibly exogenous source of time variation in our empirical framework. This allows us to
construct an additional instrument for early-life mortality.
Our empirical analysis documents that the advent of vaccination in 1801 together with
the introduction of compulsory vaccination in 1816 had profound negative e¤ects on the infant
mortality rate in Sweden. In particular, a one-standard-deviation higher level of pre-vaccination
smallpox mortality is associated with a decrease in infant mortality of about 20 deaths per 1000
live births, while compulsory vaccination yields to infant mortality a reduction of about 5 deaths
per 1000 live births. Using these two intervention episodes to obtain the causal e¤ect of early-
life mortality on fertility behavior, our results show, in line with Galor (2011), that while the
decline in infant mortality has a negative e¤ect on fertility, there is no statistically signicant
e¤ect on the number of surviving children. Because of the fertility adjustment, we nd that
the decline in infant mortality has no e¤ect on natural population growth.4
The Swedish case is interesting for a number of additional reasons. First, smallpox was a
severe disease in Sweden which killed approximately 10 percent of the population in the second
half of the 18th century (Fenner et al., 1988). Second, Sweden and the other Scandinavian
countries provided an example for the rest of the world. Subject to severe endemic and
epidemic smallpox before vaccination became available, they eliminated smallpox by the end
of the 19th century.(Fenner et al., 1988). Third, Sweden has been used as a typical example
of the fertility transition (Weil, 2009, p.104105) and health transition (Weil, 2014, p.634).
Our paper contributes to the recent literature on the historical fertility decline based on
panel data. Angeles (2010), Murtin (2013) and Hansen et al. (2014) all estimate dynamic panel
models using lagged values as instruments for endogenous variables. Angeles (2010) concludes
that child mortality plays a large role for fertility decline, while Murtin (2013) and Hansen et al.
across countries.
4This nding also supports the assumption in Ashraf et al. (2008), who simulate the economic consequences
of a health shock, that in the long run fertility adjusts to mortality, so that population growth is una¤ected.
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(2014) suggest that infant and child mortality is not robustly correlated with fertility.5 As these
studies use lagged variables as instruments for infant or child mortality, this naturally brings
into question whether their ndings can be given a causal interpretation. A notable exception
is Murphy (2010) who nds little e¤ects of infant mortality by instrumenting infant mortality
by deviations from mean temperature in a panel study of fertility in French departements
from 1876-1896. While an improvement over other studies, the exclusion restriction may be
questioned as it has been argued that temperature directly e¤ects fertility. These e¤ects may
result from changes in coital frequency or from direct physiological e¤ects(Lam and Miron,
1996, p.292). Conley et al. (2007) use the percentage of population at risk of malaria as an
instrument for infant mortality and nd a strong, positive impact on fertility, but they also
mention that malaria risk may a¤ect fertility directly. Compared to the previous studies we
provide an identication strategy for which it is less plausible that the introduction of vaccine
and the pre-vaccination distribution of smallpox has a direct impact on fertility.6
Our paper also builds on the literature on health, education, and economic growth which
uses disease eradication in a di¤erences-in-di¤erences framework to obtain identication. Our
identication strategy builds on Bleakley (2007) who combines the timing of hookworm eradi-
cation in the US South with the pre-eradication distribution of hookworm to obtain its e¤ects
on education.7 In a similar vein, we use the pre-vaccination distribution of smallpox mortality
to capture what areas would experience the greatest decreases in infant mortality after the
intervention. We also go one step further and exploit this variation in an instrumental variables
approach similar to that of Acemoglu and Johnson (2007) and Hansen (2014) to obtain a causal
e¤ect of infant mortality on fertility.
Moreover, our paper belongs to a relatively small literature on the causes of the Swedish
fertility transition using disaggregated data. Schultz (1985), Dribe (2009) and Lagerlöf (2014)
5All these studies consider relatively long panels. Angeles (2010) covers 19552000 for a world sample, Murtin
(2013) covers 18702000 for a world sample, and Hansen et al. (2014) cover 18401980 for US states.
6An older literature also proposed instrumental variables estimation. Benefo and Schultz (1996) use presence
of malaria eradication and child immunization programmes as an instrument for child mortality in Ghana and
Cote dIvoire. These programmes tend to be elded in poorer, more remote regions of Ghana, where women
are relatively less educated (Benefo and Schultz, 1996, p. 133), raising doubts about the validity of these
instruments. Our strategy avoids their issue by the fact that vaccination reached the Swedish regions at the
same time, and the fact that vaccination was not conditional on poverty.
7Bleakley and Lange (2009) also nd that fertility decreased upon the eradication of hookworm in the US
south, whereas Lucas (2013) nds that fertility increased after the eradication of malaria in Sri Lanka.
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apply county level data to study the determinants of fertility across Swedish counties. These
studies nd that changes in the price of womens time (Schultz, 1985), industrialization and the
expansion of education (Dribe, 2009) or variation in harvests and grain prices (Lagerlöf, 2014)
were important determinants of the fertility transition in Sweden. Compared to these studies
we use an identication strategy that exploits the pre-vaccination distribution of smallpox
mortality together with the introduction of the smallpox vaccine to obtain a causal e¤ect of
early-life mortality on fertility at the parish level.
The rest of the paper is structured as follows. Section 2 presents a simple theoretical model
and discusses the theoretical predictions regarding the relation between early-life mortality and
fertility. Section 3 provides background on the history of smallpox vaccination in Sweden and
descriptive evidence on early-life smallpox mortality. Section 4 presents the data. Section
5 explains our estimation framework. Sections 6 presents the empirical results. Section 7
concludes.
2 Theory
This section outlines a simple one-period static model that provides us with some straightfor-
ward testable predictions on the e¤ects of early-life mortality on fertility (children ever born)
and net fertility (i.e., surviving children).
Consider a household that derives utility from normal consumption, c, and the number of
born children, nb:
V = ln c+  lnnb, (1)
where  is the infant (or child) survival rate (i.e., 1    = the infant mortality rate). The
construction of the proposed utility function in equation (1) implies that the household receives
utility from surviving children, and that the marginal utility from born children is increasing
in the survival rate.8 The household is confronted with the following budget constraint:
8This way of theoretically modelling the relationship between (infant) mortality and fertility has recently
been applied by Strulik (2014), for example, who also nd that the decline in infant mortality plays no role in
explaining the fertility transition.
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(+ )nb + c = w, (2)
where  +  is the cost of raising a born child. This cost involves a xed term, , which is
independent of the survival rate,9 such that the cost of raising a non-surviving child is always
larger than zero; otherwise the cost per child is increasing in the survival rate, . The total
household income is denoted by w.
The problem for the household consists of maximizing equation (1) subject to equation (2).
The explicit solution for the number of children born is:
nb =

(1 + ) (+ )
w. (3)
The number of surviving children is given by:
nn = nb =
2
(1 + ) (+ )
w. (4)
It is evident from equations (3) and (4) that if the xed costs of children are not too
large (i.e.,  > 
1
2 ), fertility, nb, is decreasing in the survival rate, whereas the number of
surviving children, nn, is (unambiguously) increasing concave in the survival rate. Intuitively,
this happens because the positive extensive e¤ect which comes from the fact that the number
of surviving children is per denition increasing in the survival rate (holding the number of
born children constant) always dominates the negative intensive e¤ect (i.e., @n
b
@
< 0).
In sum, this theory predicts that an increase in the survival rate (i.e., a decline in infant
mortality) has the following implications:
1. a negative e¤ect on the number of born children if  > 
1
2 ,
2. a small but positive e¤ect on the number of surviving children.
It is worthwhile to note that these predictions are relatively robust. First, they are inde-
pendent of the curvature of the utility function, that is, similar results are obtained assum-
ing u0(x) > 0 and u00(x) < 0, x = c; nb. Second, if we assume that the cost of children is
9One can think  as a cost which is related to reduced productivity in the labor market during pregnancy.
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related to the household unit-time endowment, so that the budget constraint takes on the
form
 

w
+ 

nbw + c = w, the testable predictions also remain unchanged. On the other
hand, suppose that the households preferences instead are represented by the utility function
W = ln c + lnnb as in Galor (2011), then while our rst prediction remains una¤ected, the
e¤ect on surviving children is now predicted to be zero.10
3 Historical Background
In this section, we discuss the historical background for the introduction of vaccination and
the subsequent compulsory vaccination law which we use in our empirical analysis. Further,
we substantiate that smallpox, which is also known as variola virus, mainly impacted infants
and young children. We further demonstrate that the Swedish age distribution of smallpox
mortality rates during the late 18th and early 19th century is not qualitatively di¤erent from
those of other countries for which early data are also available.
3.1 Introduction of vaccination and compulsory vaccination law in
Sweden
Smallpox vaccination came into use in Sweden at the end of 1801 (Peterson, 1912; Sköld,
1996), and was made compulsory in 1816 (Sköld, 1996). In this subsection, we discuss how
smallpox vaccination was introduced and provide further historical background information
that is relevant to understand our empirical setting.
Prior to the invention of vaccination, the practice of inoculation was used as a preventive
measure against smallpox. Inoculation is a deliberate infection with smallpox via the skin in
the hope that a mild but immunizing e¤ect would be the outcome (Baxby, 1996). Sköld (1996,
p. 247) concludes that: Inoculation against smallpox was introduced in Britain in 1721, but
was not practised in Sweden until 1756, and even then the method encountered di¢ culties in
gaining acceptance.The likely reasons for public skepticism against inoculation as stated by
Sköld (1996, pp.294-296) were a high risk of dying from the procedure, it could serve as a source
10See Galor (2011) for the theoretical conditions under which prediction (2) is reversed.
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of infection for those not inoculated, the cost of inoculation, and general conservatism in the
public. Sköld (1996, p. 355) concludes that inoculation did little to lower mortality in Sweden
in the 18th century, and that this was also largely true for the rest of Europe.
In 1798, Edward Jenner published An Inquiry into the causes of Variolae Vaccinae, Dis-
covered in some of the Western Counties of England, particularly Gloucestershire, and known
by the name of Cow Pox which described the method of vaccination against smallpox. Jenner
carried out his rst vaccination on eight year old James Phipps in 1796. He inoculated the
boy with cowpox, and eight weeks later he inoculated him with smallpox, and as there was no
reaction, he concluded that the vaccine was e¤ective.
A few years after Jenners discovery, vaccination reached Sweden and was rst mentioned
on December 7th, 1801 by the Medical Board of Sweden. From 1803, it was o¢ cial policy that
the Inoculation House of Stockholm should keep fresh vaccine matter, though inoculation was
not banned at this stage (Sköld, 1996, p. 359). After 1803, there was no o¢ cial discussion of
inoculation. It was still used in some areas, but only when vaccination was not possible. The
rst vaccinations in Sweden have been credited to Eberhard Zacharia Munch of Rosenschöld,
who carried these out at the end of 1801 (Sköld, 1996, p.375). At rst there was skepticism
among physicians, but by the summer of 1803, most physicians and surgeons had taken up the
practice of vaccination (Sköld, 1996, p.380).
From June 1805, all church assistants should learn to vaccinate (Sköld, 1996, p.403). This
implied that there was no monopoly on vaccination. Dribe and Nystedt (2003, p.11) note that
church assistants were, in fact, the most common vaccinators. Moreover, fees for vaccination
were either very low or not charged at all, and vaccination was free for the poor. This suggests
that there are good reasons to believe that there were no di¤erences by social class in the
practise of vaccination in Sweden as argued by Sköld (1996, p.466). He also notes that the
authorities quickly adopted a strategy aiming at promoting vaccination. As early as 1804 every
parish was instructed to appoint a vaccinator and statistics on vaccination and mortality were
gathered. This served as convincing proof of the accuracy of the method to the general public.
On March 1816, the Swedish King enacted the compulsory law that all children below the
of age of two should be vaccinated. If parents did not have their children vaccinated they
would have to pay a ne. Also, in the advent of epidemics, parents were instructed to vaccinate
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their children and isolate them until the police could take care of them. If they did not, they
would have to pay a ne and in the case that they could not pay, they would be imprisoned
on a diet of water and bread (Sköld, 1996, p.449). Sköld (1996, p.255) concludes that the
e¤ect was immediate, and between 1816 and 1820 more than 73 per cent of all children were
vaccinated.An appealing feature of the compulsory vaccination law is that it was targeted the
group from 0-2 years, which suggests that it would mainly a¤ect infants and young children
(see also Section 3.2 for more details).
To gauge whether there is a substantial change in smallpox mortality when the vaccination
was introduced we plot the smallpox mortality rate and the smallpox share of total mortality
from 1750-1859 in Figures 1 and 2.11 Both graphs indicate a negative trend in both variables,
but yet there is a break in this trend in 1802 after vaccination became available. The levels of
both variables drop markedly, and while a negative trend still appears after 1802, the slope is
atter after this point.
Figures 1 and 2 about here
3.2 Descriptive evidence on early-life smallpox mortality
This subsection presents evidence that smallpox mainly a¤ected infants and young children as
argued in the literature (e.g. Sköld, 1996, Baxby, 1996). We rst consider the Swedish evidence,
and then consider suggestive evidence from other countries.
3.2.1 Evidence from Sweden
The aggregate Swedish data for smallpox mortality per 100,000 by age and time (17881854)
compiled by Sköld (1996) clearly show that mortality rates were much higher for infants and
young children (see Table 1). Before the intervention, mortality appears monotonically de-
creasing with age, but mortality rates for infants and young children drop by more than 60
percent after the introduction of vaccination in 1801. Further, while mortality for these groups
11The graphs represent averages across counties. Since there are no data on smallpox mortality available at
county level between 1774 and 1795, mortality in this period is interpolated.
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decreased monotonically over time, this is not the case for the groups above 5 years who all
experienced small increases at the end of the period. Overall, the descriptive evidence clearly
indicates that smallpox a¤ected much more infants and young children and that the e¤ect for
this age group was long-lasting.
Table 1 about here
3.2.2 Evidence from other contexts
The aggregate Swedish evidence indicates that smallpox mainly a¤ected infants and young
children. In this subsection we investigate whether the Swedish evidence is similar to other
countries. In the late 1880s, a British Royal Commission was appointed to investigate the
e¤ects of vaccination. and collected various data on smallpox deaths which are of our interest
here. Two cases are of particular interest. The rst case is presented in Table 2, which contains
data for the 1795-96 epidemic in Posen. As in Sweden, mortality rates were much higher for
infants and young children. Table 2 indicates that infants who are under 1 year had a mortality
rate of 35.9 per 100 which was three times the one for 5-10 year olds.
A second source of suggestive evidence comes from England and Wales after 1853 (the year
in which vaccination was made compulsory there). Table 3 shows that in 18511860  the
decade in which compulsory vaccination was introduced mortality of children between 0-5
years was systematically higher than in the following decade 186170. On average mortality
rates across registration divisions fell from 99.3 to 59.8 per 100,000. For children above 5 years,
there was a modest fall was from 9.09 to 7.91 per 100,000. This again corroborates that mainly
infants and young children were a¤ected by smallpox vaccination and associated compulsory
vaccination laws.12
Table 2 about here
12Davenport et al. (2011) use date on burials from St. Martin-in-the-Fields in London, England to estimate
data for mortality rates and smallpox mortality rates for infants and children. Both series show a marked fall
after 1798. A further strand of literature investigates whether there is a direct impact of smallpox survival on
height in England, see Voth and Leunig (1996), Oxley (2003) and Sharpe (2013), for example.
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Table 3 about here
4 Data
This study links aggregate (county) data on smallpox mortality from Sköld (1996) with parish
level data on birth rates and infant and child mortality from Swedish Historical Population
Statistics (SHiPS). The later statistics contain digitized information from Bastatabellen which
is a compilation of Tabellverket. Tabellverket contains information about the population in
Swedish parishes during the period 1749 to 1859, as reported by the clergymen in large forms
of tables to the Tabellkommissionen in Stockholm. These data provide parish-level information
on birth rates, infant mortality, child mortality, total mortality rate, and population size, for
example.13
Data on smallpox mortality were also compiled by the clergymen, and we use the data
reported in Sköld (1996) for the periods 17491773 and 17961859 for 25 Swedish counties.
However, because of lack of data on infant mortality for the parishes in Norbotten in the early
periods, we end up using 24 counties in the analysis. Our analysis starts in 1795, which allows us
to consider two periods prior to the vaccine introduction. One additional advantage of starting
the main analysis in 1795 is that we avoid having to deal with the fact that smallpox deaths
were reported together with measles before 1774 (Fridlizius and Ohlsson, 1984). Moreover, as
argued by Fridlizius and Ohlsson (1984) and Sköld (1996), smallpox was easy to diagnose, so
data are likely to be accurate by historical standards.
Sköld (1996) also provides vaccination rates which are calculated as the number of children
vaccinated as a proportion of children born in the previous 5 year period. For example, for
1810-1815 the variable is calculated as the number of children vaccinated divided by children
born in the period 1809-1814 (Sköld, 1996, p. 571). We also add some control variables, which
generally are introduced as the analysis progresses. The dataset we end up using is a 5-year
balanced panel from 17951860 with 24 counties and 777 parishes. Further details about the
data and summary statistics are provided in the supplementary online appendix.
13The digitized data are made available by Umeå University at http://ships.ddb.umu.se/
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5 Identication strategy
This section describes how we propose to identify the e¤ect of early-life mortality on fertility
and surviving children. Our baseline estimation equation takes the following functional form:
yijt =  Infant mortality ijt +Xijt + j + t + "ijt; (5)
where yijt denotes the outcome of interest  the birth rate, surviving children, or natural
population growth  in a Swedish parish i of county j at time t 2 (1795; 1860). The main
variable of interest, Infant mortality ijt, is the infant mortality rate as measured by the number
of infant deaths per 1000 live births. We further include a set of parish-specic control variables,
Xijt, such as, initial infant mortality and population size (interacted with the time indicator
variable; see below) and county (j) and time (t) xed e¤ects.14 We cluster the error term "ijt
at the county level to ensure that the standard errors of our estimates are robust to arbitrary
correlation across parishes in each Swedish county. We restrict the sample to parishes that are
observed for all years. In the online appendix we also report the estimates for the unbalanced
panel of parishes for which we obtain qualitatively similar results.
While the panel structure of the dataset allows us to perfectly control for time invariant
county-specic (or parish-specic) characteristics a¤ecting both mortality and fertility, the OLS
estimate of  does not necessarily measure the causal e¤ect because of reverse causation, that
is fertility is likely to also inuence mortality, and omitted variable bias due to time varying un-
observed factors, for example. For these reasons, our empirical strategy exploits two important
episodes in the relation to the advancement of vaccination against smallpox, which induced a
sharp decline in smallpox mortality. The rst episode is the introduction of the vaccination
method after 1801, and the second is the enactment of the compulsory vaccination law in 1816.
The time variation from these episodes combined with cross-county di¤erences in pre-
treatment smallpox mortality rates represent our di¤erences-in-di¤erences approach, which we
use as the rst stage of our two-stage least squares (2SLS) estimation approach to estimate the
e¤ect of mortality on fertility.
14We also also report estimates on infant mortality that control for parish xed e¤ects instead of county xed
e¤ects.
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We consider the following rst-stage relationship:
Infant mortality ijt = 1 S
pre_I
j  I t>1801t + 2 S pre_IIj  I t>1816t
Xjt  + j + t + "ijt; (6)
where S pre_Ij is the smallpox mortality rate measured prior to the introduction of vaccination
in 1796-1801 in county j and I t>1801t is an indicator variable that equals one for the period after
1801 (i.e., 1805, 1810, .., 1860). In a similar way, S pre_IIj is the smallpox mortality rate measured
just before the enactment of the compulsory vaccination law of 1816 and I t>1815t is an indicator
that equals one afterwards. The remaining variables are dened above. Notice, the two shock
variables, S pre_Ij  I t>1801t and S pre_IIj  I t>1816t , which we shall refer to as Vaccination and
Law 1816 jt in the regression tables, vary only at the county-by-year level (we only have data
on smallpox mortality at the county level). The regressions are weighted by initial parish-
population size, so that the estimates reect an average population e¤ect.15 If we nd that
^1 < 0 and ^2 < 0, then the introduction of the vaccination method and the compulsory
vaccination law decreased infant mortality.
Finally, because the adoption of vaccination is endogenous, the identication strategy relies
on an intention-to-treat design, where counties with a higher level of smallpox mortality was
given a more advantageous shock (in terms of reducing mortality) when the vaccination tech-
nology di¤used. However, in contrast to many previous studies, which follow a similar approach
(e.g., Bleakley, 2007; Acemoglu and Johnson, 2007; Hansen, 2014), we can study whether the
counties with a higher burden of smallpox mortality actually had a higher level of adoption of
the new technology. This is possible because we have data on vaccination rates at the county
level.
15The unweighted least squares regressions yield similar results and are available from the authors upon
request.
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6 Empirical Results
6.1 The e¤ect of vaccination on infant mortality
6.1.1 Main results
Table 4 presents our main results for the rst-stage relationship. The estimation equation is
(6) and the method of estimation weighted least squares. Column (1) demonstrates that infant
mortality rates are strongly and negatively a¤ected by the introduction of vaccination, as we
observe a negative and statistically signicant coe¢ cient on the shock variable S pre_Ij  I t>1801t ,
which we refer to as Vaccination in the following tables. The point estimate is statistically
signicant at the 1 percent level.
One concern might be that this coe¢ cient might pick up some sort of convergence or diver-
gence process in outcome at the parish level. Hence, we control in column (2) for the infant
mortality rate in 1800 (Initial mortality) and the log initial population size (Initial popula-
tion) interacted with the indicator, I t>1801t . The coe¢ cient increases in numerical magnitude,
such that a one-standard-deviation increase in smallpox mortality prior to the breakthrough of
vaccination is associated with a decline in infant mortality of 16.4 deaths per 1000 live births af-
terwards, which corresponds to 0.11 of a standard deviation in the pretreatment infant-mortality
rate.
Columns (3) and (4) consider the compulsory vaccination law measured by S pre_IIj  I t>1816t
(Law 1816 ) as alternative shock variable. While the estimated coe¢ cient is negative and
statistically signicant in both specications, we see that controlling for Vaccination in column
(5), increases the numerical magnitude substantially. In the specications that only include the
shock from the vaccination law but disregard the shock from the introduction of vaccination,
the estimate of ^2 is biased towards zero if the two intensity measures (i.e., S
pre_I
j and S
pre_II
j )
are negative correlated and Vaccination has a negative e¤ect on infant mortality (in our case
both conditions are satised).16 Thus, in column (5), where Vaccination and Law 1816 are
included together the e¤ect increases in magnitude. The magnitude of the estimated coe¢ cient
16The negative correlation between Spre_Ij and S
pre_II
j can be explained by the fact that counties with higher
level of smallpox mortality in 1795-1801 received a more favorable shock due to the introduction of vaccination.
Accordingly, the level of smallpox mortality could be lower in these places 15 years later.
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on Law 1816 implies that a one-standard-deviation higher level of smallpox mortality before the
enactment of the compulsory vaccination law is associated with a decrease in infant mortality
of 4.7 deaths per 1000 live births afterwards, which is the same as 0.05 of a standard deviation
in the pretreatment infant mortality rate. In this specication, the e¤ect of Vaccination is 19.5
deaths per 1000 live births. As the intention-to-treatis higher around the rst shock, we nd
that the introduction of vaccination had a large e¤ect on the development of infant mortality
compared to the vaccination law.
Table 4 about here
Before presenting the robustness analysis for the baseline rst-stage estimates, it is worth-
while to note that we reach the same conclusion estimating a exible model with the e¤ects
for each time period from 1795 to 1860. Table 2a of the supplementary online appendix shows
a discontinuity in the coe¢ cients for both interventions around the adoption dates, and the
p-values of the F-tests reveal that the coe¢ cients in the post-treatment years are jointly sta-
tistically di¤erent from the estimated coe¢ cient(s) in the pretreatment year(s) at conventional
levels. The results from the exible specication also suggest that our (pre-treatment) small-
pox mortality rates, S pre_Ij and S
pre_II
j , are not correlated with pre-existing trends in infant
mortality.
6.1.2 Robustness
In this subsection, we have carried out a number of robustness checks which are based on
estimation equation (6). The method of estimation is weighted least squares. First, if counties
had di¤erent trends in mortality prior to the interventions, the decrease in infant mortality could
have happened irrespectively of the interventions. While the presence of initial mortality rates
as a baseline control variable should soak up mean reversion in the outcome, Table 5 considers
whether pre-existing trends in infant mortality could account for our baseline results. As a rst
check, columns (1) and (2) show the results from a falsication test where the outcome variable
is the infant mortality rate in the 50-year period preceding the introduction of the vaccination
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method in Sweden (i.e., 17501800). We observe that the coe¢ cients are now positive on both
interactions suggesting that our baseline estimates are not capturing a pre-existing downward
trend in infant mortality. In the next two columns, we add a placebo intensity measure (i.e.,
smallpox mortality in 17491753), which is the period prior to the introduction of inoculation
in Sweden. While the coe¢ cients of interest remain reassuringly stable in both magnitude
and statistical signicance, the estimated e¤ect of the placebo shock variable is basically zero.
Moreover, in that respect, estimating a model (for the period 17501795) where we, in the same
way, attempt to capture the introduction of the inoculation method, we nd that the coe¢ cient
on the inoculation-shock variableis  0:09 (standard error = 0:08).17 Thus, in line with the
view of Sköld (1996), there is no evidence of the inoculation method reducing infant mortality,
which also indicates that our interactions do not capture pre-existing trends set in motion from
the introduction of inoculation into Sweden. Finally, we control for trend di¤erences across
areas by including county-specic time trends. Nevertheless, estimates of this model, reported
in columns (5) and (6) show little changes in the estimated 0s.
Table 5 about here
Table 6 reports additional sensitivity tests. The rst three columns replace the intensity
measure of our interactions (i.e., the smallpox mortality rate) with the share of smallpox mor-
tality out of total mortality. The two new intervention variables, which are indicated alternative
in the Table 6, take into account the possibility that smallpox mortality is correlated with other
diseases. While the literature stresses that smallpox mortality was the only disease which ex-
hibited a signicant decline around this period of time, our baseline interactions might capture
declines in other diseases as well. However, as observed in columns (1)(3), the estimates on the
alternative interactions are also negative and statistically signicant at the 1 percent level.
This means that parishes in counties with a high share of smallpox mortality before the advent
of vaccination and before the vaccination law experienced greater decreases in infant mortality
afterwards. Column (4) demonstrates that our baseline estimates are robust to controlling for
the number of still births. In some unreported specication, we demonstrate that Vaccination
17This result is available upon request.
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has a small positive and statistically signicant e¤ect on still births.18 This nding is not sur-
prising as parents giving birth in, for example, 1810, which is in the post-treatment period,
were not exposed to an environment with less smallpox mortality in general since the method
of vaccination was unavailable in their childhood. In the words of the 2SLS strategy followed
in Section 7, the coding of the time indicator implies that our interaction, S pre_Ij  I t>1801t , is
not likely to capture a direct biological e¤ect from the parents on fertility.19
Columns (5)(7) add indicators for the economic environment. Specically, we add the price
of rye and the log of rye production per capita as indicators of county level income (see Dribe
et al., 2011). We add these income indicator to our estimation equation, as compliance to
the compulsory vaccination law was more costly for poorer families. Yet, we observe that the
estimated e¤ect of (compulsory) vaccination remains una¤ected by including these controls.
Finally, it is worthwhile to note that we generally obtain similar results controlling for
parish xed e¤ect instead of county xed e¤ect, which indicates that our results are not driven
by unobserved time-invariant factors at the parish level. This also becomes clear when we
present our 2SLS estimates in Section 6.2.
Table 6 about here
6.1.3 Alternative outcomes
We next consider alternative outcome variables. Our approach is an intention-to-treat design,
and we posit that our measures capture increases in vaccination and decreases in smallpox
mortality. The rst four columns of Table 7 validate our approach. Columns (1) and (2)
exploit the fact that we have a measure for the adoption of vaccination, that is, the outcome
variable is now county is vaccination rate for the children in the age group 05 at time t. The
estimated coe¢ cients on both interventions are positive and statistically signicant at the 5
18These results are available from the authors upon request.
19Rutten (1993) and Sköld (1996) note that some authors have proposed that male fecundity was a¤ected by
smallpox e.g. because infected men would be disadvantaged in the marriage markets due to pockmarks. Sköld
(1996, p. 195) demonstrates that infected and vaccinated had similar fecundity levels. Rutten (1993) presents
similar evidence for the Netherlands. Thus, the empirical evidence tends to reject this e¤ect of smallpox.
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percent level. This implies that counties with a higher level of intention-to-treatbefore the
interventions also had higher adoption rate of the new technology afterwards.
The idea in the intention-to-treat design is that equation (6) is the reduced form of the
following rst stage:20
Smallpox mortality it = 1 S
pre_I
j  I t>1801t + 2 S pre_IIj  I t>1816t +
Xjt  + j + t + "ijt; (7)
where Smallpox mortality it is the smallpox mortality rate in county i at time t. Columns
(3) and (4) report the coe¢ cients of estimating this equation. The estimated coe¢ cients of
the two interaction terms are positive and highly statistically signicant. These results would
imply that one could use a three-stage least squares (3SLS) approach, i.e. S pre_Ij  I t>1801t and
S pre_IIj I t>1816t ) Smallpox mortality it ) Infant mortality) yijt. However, having established
the rst chain in this line of argumentation in columns (3) and (4), we follow the literature
and regress directly infant mortality on the two interactions, implying that we end up with the
suggested 2SLS model.
Columns (5) and (6) report the estimates for child mortality for the age group 15, while
columns (7) and (8) report the estimates for the total mortality rate. We observe that both
are reduced as a consequence of vaccination, but also notice that the observed e¤ects are
signicantly smaller on the total mortality rate as compared to child and infant mortality. In
particular, the estimated coe¢ cient for the total mortality rate (in column 8) implies that a
one-standard-deviation increase in the pre-intervention smallpox-mortality rate is associated
with a decrease in the death rate of 1.1 deaths per 1000 population afterwards. This number
corresponds to 0.09 of a standard deviation in the total death at time t = 1800. Thus, consistent
with the arguments in the literature, the method of vaccination had most profound e¤ects on
infant and child mortality. Finally, the vaccination law does not have the same quantitative
e¤ect on these measures, which is arguably related to the fact that compulsory vaccination was
for 02 year old.
20In our 2SLS notation this equation should be referred to as the zero-stage.
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Table 7 about here
6.2 The e¤ect of infant mortality on fertility
This section reports the main results of the paper, which are the 2SLS estimates of the e¤ect
of infant mortality on four di¤erent outcomes: 1) the birth rate (fertility), which is the number
of live births per 1000 population, 2) surviving children to the age of one, dened as the birth
rate times the infant survival probability, 3) surviving children to the age of ve, and 4) natural
population growth. The results for these outcomes are shown in Tables 811.21 The estimating
equation is (5) and the method of estimation is 2SLS weighted by initial parish population size.
Table 8 shows six di¤erent specications. Columns (1)(3) show the results for the baseline
setup with county and time xed e¤ects. In addition to xed e¤ects for periods and counties,
column (1) includes only infant mortality instrumented by S pre_Ij  I t>1801t . In line with theo-
retical predictions, the result is a positive coe¢ cient on infant mortality which is signicant at
the 5 percent level. In terms of magnitude, the coe¢ cient suggests that decreasing the infant
mortality rate by 20 deaths per 1000 live births decreases the number of birth by about 1 per
1000 population. Column (2) shows that this estimate is robust to our baseline controls. In
column (3), we add the instrument based on the timing of the compulsory vaccination law,
and see that this leads to a slightly smaller estimate on infant mortality, but the estimated
coe¢ cient remains statistically signicant at the 1 percent level.
In terms of instrument quality, the instrumental variables estimation strategy yields a rea-
sonable rst-stage t. The Kleibergen-Paap F-statistic reported in column (3) of Table 8 is
16. A Kleibergen-Paap F-statistic above 10 mitigates the concern that our statistical inference
yields misleading results due to the presences of weak instruments (Stock et al., 2002). More-
over, since our 2SLS regressions are overidentied, we can compute the Hansen J-test on the
joint hypothesis that our instruments (Vaccination and Law 1816 ) are uncorrelated with the
second-stage error term. With a p-value of 0.376, the Hansen J-test does not reject the joint
hypothesis that the two instrumental variables are uncorrelated with the second-stage error
21Note that the p-values in square brackets refer to the AndersonRubin test of statistical signicance.
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term. Given we can assume exogeneity of S pre_Ij  I t>1801t , then we cannot reject the null that
S pre_IIj  I t>1816t is a valid instrument. Columns (4)(6) show results for similar, but more
demanding specications where we replaced county xed e¤ects by parish xed e¤ects. The
coe¢ cients on infant mortality in columns (4) and (6) are similar in magnitude to the ones
reported in columns (1) and (3), respectively.22
Table 8 about here
Tables 9 and 10 replace the birthrate by measures of surviving children as the outcome
variable. Table 9 reports the estimates for the number of children surviving to the age of
one, which is constructed as the birth rates times the survival probability. We observe that
across specications, the coe¢ cient on infant mortality is mostly statistically insignicant,
which is a result of the fact that the coe¢ cient reduces in magnitude and not because it is
imprecisely estimated. Thus, a decrease in the number of births, caused by a decrease in the
infant mortality rate, does not translate into less surviving children as more children survive.
That is, in accordance with the theory of Galor (2011), the extensive e¤ect outweight the
intensive e¤ect from Table 6. Table 10 reveals similar conclusions for the number of children
surviving to the age of ve, which is constructed as the birth rates times the probability of
survival to the age of ve.
Tables 9 and 10 about here
Finally, Table 11 reports the e¤ects on natural population growth as measured by the birth
rate minus the death rate. Consistent with the previous results infant mortality has no e¤ect
on population growth. These ndings are not due to weak rst stages as we see the rst-
stage Kleibergen-Paap F-statistics is around 7 or above in all the specications. Moreover, the
22In some unreported specications, we show that our 2SLS estimates are robust to controlling for the number
still births, indicating the baseline 2SLS estimates do not capture a direct biological/cultural link from the
parents around the infant mortality rate. These estimates are available from the authors upon request.
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p-values for the Hansen J-test suggest that we cannot reject the validity of the instruments.
Thus, this evidence indicates that fertility adjusts to infant mortality, so that natural population
growth is una¤ected.
Table 11 about here
To summarize, this section demonstrates, in line with prediction (1) of Section 2 and the
theory in Galor (2011), that infant mortality has a positive e¤ect on fertility. In line with
Galors (2011) theory we show that there is no empirical evidence of an e¤ect on surviving
children.
7 Conclusion
This paper has demonstrated that infant mortality in Sweden was strongly driven by smallpox
vaccination and the associated compulsory vaccination law. Our empirical tests suggest that
this cannot be attributed to the initial mortality level, initial population, crude measures of
regional income as well as time and cross-sectional (county or parish) xed e¤ects. We then used
the vaccination variables to obtain causal estimates of the e¤ects on fertility and population
growth, and demonstrated that infant mortality was unlikely to be a driver of natural population
growth in Sweden, which is in line with the theoretical predictions of Galor (2011).
The current study used data for Sweden, and while we have shown descriptive evidence
consistent with the same mechanism being at play elsewhere, one may naturally question the
external validity of the current study. Nonetheless, Sweden and the rest of Scandinavia served as
role models for the rest of the world in combating smallpox (Fenner et al., 1988). This suggests
that the Swedish case is of interest on its own as this was one of the cases that provided the
blueprints for combating smallpox elsewhere.
Since our study suggests that infant mortality did not impact net fertility, this naturally
raises the question of what then drives net fertility? Recent research of Bleakley (2007) and
Bleakley and Lange (2009) provide evidence that is consistent with the quantity-quality trade-
o¤ theories of fertility transition. They focus on a disease the hookworm which relates to
morbidity rather than mortality suggesting that the type of disease matters for the fertility
21
response.23 These studies also point to the importance of schooling, as also suggested by the
dynamic panel analyses by Angeles (2010), Murtin (2013) and Hansen et al. (2014). Yet, none
of them provide an estimate of the causal e¤ect of schooling on fertility based on a credible,
exogenous source of variation and xed e¤ects for cross-sectional units. We believe that this is
an important task for future research.
23See also Andersen, Dalgaard and Selaya (2014) who focus on eye disease.
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Figure 1: Smallpox mortality rate for all of Sweden, 17501860
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Figure 2: Smallpox share out of total mortality, 17501860.
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Table 1: Smallpox Mortality per 100,000 by age group
0 years 1-2 years 3-4 years 5-9 years 10-24 years 25-49 years 50 years+
1788-92 2471 1339 820 293 40 2 1
1806-10 765 486 289 119 15 1 1
1831-35 410 81 39 15 10 15 1
1850-54 404 68 n/a 19 20 23 6
Notes: The table reports age-specic smallpox mortality rates for di¤erent time periods in Sweden. Source:
Sköld (1996).
Table 2: Incidence and mortality
Cases Deaths Deaths per 100
under 1 year 39 14 35.9
1-2 years 145 42 29.0
2-3 years 168 33 19.6
3-4 years 205 34 16.6
4-5 years 186 25 13.4
0-5 years 743 148 19.9
5-10 years 241 48 10.9
10-15 years 58 2 3.4
15-20 years 10 1 10.0
Notes: The table reports the number of incidence and mortality from smallpox during the 1795-1796 epidemic
in three towns in Posen. Source: Second report of the Royal Commission Appointed to Inquire into the Subject
of Vaccination.
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Table 3: Smallpox mortality before and after
compulsory vaccination
Smallpox mortality rate:
Division: Period: age 05 age 5 +
London 1851-60 130 13
1861-70 116 14
South Eastern 1851-60 56 8
1861-70 35 7
South Midland 1851-60 62 9
1861-79 39 7
Eastern 1851-60 47 5
1861-70 27 6
South-Western 1851-60 95 9
1861-70 37 4
West Midland 1851-60 123 10
1861-70 64 7
North Midland 1851-60 69 6
1861-70 39 4
North-Western 1851-60 113 5
1861-70 62 8
York 1851-60 116 8
1861-70 107 10
Northern 1851-60 117 10
1861-70 78 11
Welsh 1851-60 164 17
1861-70 54 9
Average 1851-60 99.3 9.09
1861-70 59.8 7.91
Notes: The table reports the smallpox mortality rates before and after compulsory vaccination for di¤erent
geographical areas and age groups. Source: First report of the Royal Commission Appointed to Inquire into
the Subject of Vaccination.
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Table 4: Main results
Dependent Variable: Infant Mortality Rate
(1) (2) (3) (4) (5)
Vaccination -0.327*** -0.370*** -0.439***
(0.121) (0.117) (0.118)
Law 1816 -0.248** -0.228** -0.543***
(0.110) (0.114) (0.104)
Controls (I t>1801):
Initial mortality 0.0538*** 0.0471*** 0.0540***
(0.0145) (0.0174) (0.0146)
Intial population 3.826 0.940 3.474
(3.365) (2.852) (3.380)
Observations 10,878 10,878 10,878 10,878 10,878
Notes: The left-hand-side variable is infant mortality measured as the number of death per 1000 born at the
parish level between 17951860. The table reports least squares estimates, weighted by log population size
in 1800. All regressions include county and year xed e¤ects. Vaacination is the smallpox mortality rate
in 17961801 interacted with an indicator that equals one after 1801. Law 1816 is constructed as smallpox
mortality prior to the vaccination law of 1816 (i.e., 18111815) interacted with an indicator that equals one
after 1816. Initial mortality is the infant mortality rate in 1800 and initial population is log population size in
1800. Constants are not reported. Robust standard errors are clustered at the county level.
*** p<0.01, ** p<0.05, * p<0.1.
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Table 5: Falsication and pre-existing trends
(1) (2) (3) (4) (5) (6)
Dependent Variable:
Infant Mortality Infant Mortality Rate
Rate 17951860
17501800
Vaccination 0.215 0.219* -0.350*** -0.418*** -0.546*** -0.553***
(0.130) (0.121) (0.115) (0.120) (0.109) (0.109)
Law 1816 0.0376 -0.508*** -0.448***
(0.426) (0.104) (0.130)
Placebo intensity 0.0901 0.0744
(0.0698) (0.0712)
Controls (I t>1801):
Initial mortality Yes Yes Yes Yes Yes Yes
Intial population Yes Yes Yes Yes Yes Yes
County linear trends No No No No Yes Yes
Observations 7,204 7,204 10,842 10,842 10,842 10,842
Notes: The left-hand-side variable is infant mortality measured as the number of death per 1000 born at the
parish level between 17501800 in columns (1)-(2) and 17951860 in columns (3)-(6). The table reports least
squares estimates, weighted by log population size in 1800. All regressions include county and year xed e¤ects.
Vaacination is the smallpox mortality rate in 1796-1801 interacted with an indicator that equals one after 1801.
Law 1816 is constructed as smallpox mortality prior to the vaccination law of 1816 (i.e., 1811-1815) interacted
with an indicator that equals.one after 1816. Placebo intensity is smallpox mortality in 1749-1753 interacted
with an indicator that equals one after 1801. Initial mortality is the infant mortality rate in 1800 and initial
population is log population size in 1800. Constants are not reported. Robust standard errors are clustered at
the county level.
*** p<0.01, ** p<0.05, * p<0.1.
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Table 8: The e¤ect on fertility
Dependent Variable: Birth rate
(1) (2) (3) (4) (5) (6)
Infant mortality 0.0542*** 0.0533*** 0.0421*** 0.0542*** 0.166*** 0.0527*
(0.0205) (0.0176) (0.0141) (0.0205) (0.0529) (0.0308)
Anderson-Rubin [p-value] [0.011] [0.004] [0.008] [0.011] [0.002] [0.006]
Controls (I t>1801):
Initial mortality No Yes Yes No Yes Yes
Intial population No Yes Yes No Yes Yes
Instruments:
Vaccination Yes Yes Yes Yes Yes Yes
Law 1816 No No Yes No No Yes
Kleibergen-Paap
F-statistic 6.95 9.47 16.00 6.97 7.65 12.64
Hansen-J [p-value] - - [0.376] - - [0.066]
County xed e¤ects Yes Yes Yes No No No
Parish xed e¤ects No No No Yes Yes Yes
Obsservations 10,878 10,878 10,878 10,878 10,878 10,878
Notes: The left-hand-side variable is the birth rate measured as the number of live births per 1000 populations
at the parish level between 17951860. The table reports two-stage least squares estimates for infant mortality,
weighted by log population size in 1800. All regressions include year xed e¤ects. Infant mortality is the number
of death per 1000 born. Vaccination is the smallpox mortality rate in 1796-1801 interacted with an indicator
that equals one after 1801. Law 1816 is constructed as smallpox mortality prior to the vaccination law of 1816
(i.e., 1811-1815) interacted with an indicator that equals one after 1816. Initial mortality is the infant mortality
rate in 1800 and initial population is log population size in 1800. Constants are not reported. Robust standard
errors are clustered at the county level.
*** p<0.01, ** p<0.05, * p<0.1.
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Table 9: The e¤ect on surviving children to the age of one
Dependent Variable: Surviving Children (age 1)
(1) (2) (3) (4) (5) (6)
Infant mortality 0.0187 0.0172 0.00646 0.0187 0.108** 0.0117
(0.0176) (0.0150) (0.0117) (0.0176) (0.0460) (0.0258)
Anderson-Rubin [p-value] [0.229] [0.202] [0.394] [0.229] [0.006] [0.016]
Controls (I t>1801):
Initial mortality No Yes Yes No Yes Yes
Intial population No Yes Yes No Yes Yes
Instruments:
Vaccination Yes Yes Yes Yes Yes Yes
Law 1816 No No Yes No No Yes
Kleibergen-Paap
F-statistic 6.95 9.47 16.00 6.97 7.65 12.64
Hansen-J [p-value] - - [0.330] - - [0.069]
County xed e¤ects Yes Yes Yes No No No
Parish xed e¤ects No No No Yes Yes Yes
Obsservations 10,878 10,878 10,878 10,878 10,878 10,878
Notes: The left-hand-side variable is surviving children age 1, which is constructed as the birth rate time the
probability of surviving to the age of one at the parish level between 17951860. The table reports two-stage
least squares estimates for Infant mortality, weighted by log population size in 1800. All regressions include
year xed e¤ects. Infant mortality is the number of death per 1000 born. Vaccination is the smallpox mortality
rate in 1796-1801 interacted with an indicator that equals one after 1801. Law 1816 is constructed as smallpox
mortality prior to the vaccination law of 1816 (i.e., 1811-1815) interacted with an indicator that equals one after
1816. Initial mortality is the infant mortality rate in 1800 and initial population is log population size in 1800.
Constants are not reported. Robust standard errors are clustered at the county level.
*** p<0.01, ** p<0.05, * p<0.1.
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Table 10: The e¤ect on surviving children to the age of ve
Dependent Variable: Surviving Children (age 5)
(1) (2) (3) (4) (5) (6)
Infant mortality -0.00775 -0.00295 0.000354 -0.00798 0.0467 0.0224
(0.0144) (0.0132) (0.0140) (0.0157) (0.0370) (0.0375)
Anderson-Rubin [p-value] [0.601] [0.826] [0.960] [0.617] [0.220] [0.452]
Controls (I t>1801):
Initial mortality No Yes Yes No Yes Yes
Intial population No Yes Yes No Yes Yes
Instruments:
Vaccination Yes Yes Yes Yes Yes Yes
Law 1816 No No Yes No No Yes
Kleibergen-Paap
F-statistic 7.86 10.07 13.44 7.92 14.07 14.23
Hansen J [p-value] - - [0.795] - - [0.618]
County xed e¤ects Yes Yes Yes No No No
Parish xed e¤ects No No No Yes Yes Yes
Obsservations 9,015 9,015 9,015 9,015 9,015 9,015
Notes: The left-hand-side variable is surviving children age 5, which is constructed as the birth rate time the
probability of surviving to the age of ve at the parish level between 17951860. The table reports two-stage
least squares estimates for Infant mortality, weighted by log population size in 1800. All regressions include
year xed e¤ects. Infant mortality is the number of death per 1000 born. Vaccination is the smallpox mortality
rate in 1796-1801 interacted with an indicator that equals one after 1801. Law 1816 is constructed as smallpox
mortality prior to the vaccination law of 1816 (i.e., 1811-1815) interacted with an indicator that equals one after
1816. Initial mortality is the infant mortality rate in 1800 and initial population is log population size in 1800.
Constants are not reported. Robust standard errors are clustered at the county level.
*** p<0.01, ** p<0.05, * p<0.1.
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Table 11: The e¤ect on natural population growth
Dependent Variable: Natural Population Growth
(1) (2) (3) (4) (5) (6)
Infant mortality 0.00717 0.000587 -0.000308 0.00717 0.0807 0.0229
(0.0252) (0.0194) (0.0209) (0.0252) (0.0582) (0.0572)
Anderson-Rubin [p-value] [0.764] [0.976] [0.999] [0.764] [0.097] [0.244]
Controls (I t>1801):
Initial mortality No Yes Yes No Yes Yes
Intial population No Yes Yes No Yes Yes
Instruments:
Vaccination Yes Yes Yes Yes Yes Yes
Law 1816 No No Yes No No Yes
Kleibergen-Paap
F-statistic 6.95 9.47 15.97 6.97 7.65 12.62
Hansen-J [p-value] - - 0.966 - - 0.442
County xed e¤ects Yes Yes Yes No No No
Parish xed e¤ects No No No Yes Yes Yes
Obsservations 10,877 10,877 10,877 10,877 10,877 10,877
Notes: The left-hand-side variable is natural population growth, constructed as the birth rate minus the death
rate at the parish level between 17951860. The table reports two-stage least squares estimates for Infant
mortality, weighted by log population size in 1800. All regressions include year xed e¤ects. Infant mortality
is the number of death per 1000 born. Vaccination is the smallpox mortality rate in 1796-1801 interacted with
an indicator that equals one after 1801. Law 1816 is constructed as smallpox mortality prior to the vaccination
law of 1816 (i.e., 1811-1815) interacted with an indicator that equals one after 1816. Initial mortality is the
infant mortality rate in 1800 and initial population is log population size in 1800. Constants are not reported.
Robust standard errors are clustered at the county level.
*** p<0.01, ** p<0.05, * p<0.1.
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